← ANALYST RATINGS · TIPRANKS
LifeMD (LFMD): analyst forecast and price target
Analyst consensus
Strong Buy7 Buy0 Hold0 Sell
Ratings of 7 analysts in the last 3 months12-month forecast
Based on 7 price targets given in the last 3 months, the average target is $8.29, the highest $15.00, the lowest $5.00. The average is +254.1% from the last price of $2.34.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Healthcare Information ServicesxAI Grok-3 | TipRanks - xAI | $3.00 → $2.50−16.7% | Hold | +6.8% | Reiterated | 10.10.26on TipRanks 02:05 | — | |
| AI Google Medical - Healthcare Information ServicesGemini 3-pro | TipRanks - Google | $3.00 → $2.50−16.7% | Hold | +6.8% | Reiterated | 10.10.26on TipRanks 02:05 | — | |
| AI PerPlexity Medical - Healthcare Information ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $3.00 → $2.50−16.7% | Hold | +6.8% | Reiterated | 10.10.26on TipRanks 02:05 | — | |
| AI DeepSeek Medical - Healthcare Information ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $3.00 → $2.50−16.7% | Hold | +6.8% | Reiterated | 03.10.26on TipRanks 03:05 | — | |
| AI OpenAI Medical - Healthcare Information ServicesOpenAI 5.2 | TipRanks - OpenAI | $3.00 → $2.50−16.7% | Hold | +6.8% | Reiterated | 03.10.26on TipRanks 03:05 | — | |
| AI Anthropic Medical - Healthcare Information ServicesAnthropic Opus-4.5 | TipRanks - Anthropic | $3.00 → $2.50−16.7% | Hold | +6.8% | Reiterated | 03.10.26on TipRanks 03:05 | — | |
| Yi Chen★★★★★★★★★★#10518 · hits 41% · avg −1.0% | H.C. Wainwright | $9.00 | Buy | +284.6% | Reiterated | 18.09.26on TipRanks Sep 17 11:35 | −1.4%next day +0.5% · 5 days −9.9% | ↗ |
| William Wood★★★★★★★★★★#3198 · hits 53% · avg +11.7% | B. Riley Securities | $8.00 | Buy | +241.9% | Reiterated | 11.09.26on TipRanks 08:55 | −0.2%next day +13.2% · 5 days +5.7% | ↗ |
| Scott Schoenhaus★★★★★★★★★★#12104 · hits 35% · avg −9.7% | KeyBanc | $8.00 → $5.00−37.5% | Buy | +113.7% | Reiterated | 07.08.26on TipRanks 13:55 | +4.1%next day +1.7% · 5 days −3.5% | ↗ |
| Ryan Meyers★★★★★★★★★★#11713 · hits 39% · avg −4.3% | Lake Street | $8.00 → $5.00−37.5% | Buy | +113.7% | Reiterated | 06.08.26on TipRanks 09:20 | −7.4%next day +4.1% · 5 days +0.6% | ↗ |
| Steven Valiquette★★★★★★★★★★#8240 · hits 53% · avg 0.0% | Mizuho Securities | $8.00 → $7.00−12.5% | Buy | +199.1% | Reiterated | 06.08.26on TipRanks 07:25 | −7.4%next day +4.1% · 5 days +0.6% | ↗ |
| David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% | BTIG | $10.00 → $9.00−10.0% | Buy | +284.6% | Assigned | 06.08.26on TipRanks 06:05 | −7.4%next day +4.1% · 5 days +0.6% | ↗ |
| Sarah James★★★★★★★★★★#2265 · hits 55% · avg +5.7% | Cantor Fitzgerald | $15.00 | Buy | +541.0% | Reiterated | 05.08.26on TipRanks Aug 6 08:05 | −5.4%next day −7.4% · 5 days −10.9% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering LifeMD
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $8.29 at a price of $2.90 (+185.7%); now: $8.29 at $2.34 (+254.1%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 5 | 5 | 6 | 7 | 7 |
| Buy | 1 | 0 | 0 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 11.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.14 (from $-0.26 to $-0.07). Last quarter: $-0.16.
Sales
Next quarter’s sales estimate — $49M (from $46M to $51M). Last quarter: $47M.
Best top-analyst consensus in the sector · Healthcare
About LifeMD
- CEO: Justin Schreiber
- Employees: 350
- 236 Fifth Avenue, New York City, NY, 10001, US
- www.lifemd.com
LifeMD, Inc. operates as a leading digital health company, specializing in direct-to-consumer telemedicine across the United States. The firm links individuals with licensed medical professionals to address a diverse spectrum of health concerns, including concierge services, men's sexual health, dermatological conditions, and more. Under its umbrella, LifeMD manages several specialized virtual care platforms: ShapiroMD is a telehealth brand focused on hair restoration, delivering virtual consultations, prescription medications, patented over-the-counter formulations, an FDA-cleared medical device, and custom-compounded topical treatments for both male and female hair loss. RexMD serves as a men's telehealth brand, providing virtual medical treatment from licensed providers for a wide array of male-specific health needs. LifeMD Primary Care offers a personalized, subscription-based virtual primary care solution, addressing routine, urgent, and chronic health management requirements. This mobile-centric platform integrates remote consultations, medication management, diagnostic services, and imaging referrals. Cleared is a telehealth service dedicated to offering personalized therapies for allergic, asthmatic, and immunological conditions. Nava MD stands as a skincare and tele-dermatology brand catering specifically to women, facilitating virtual access to dermatologists and other specialists for medical treatment. Additionally, the company provides PDFSimpli, a cloud-based software-as-a-service (SaaS) platform that empowers users to create, edit, convert, sign, and share PDF documents online. LifeMD distributes its offerings directly to individuals, via its own e-commerce channels, and through collaborations with external partners. Originally established in 1994 as Conversion Labs, Inc., the company rebranded to LifeMD, Inc. in February 2021 and is headquartered in New York City.
Data from the stock’s TipRanks forecast page, read 123 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗